| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/16/2005 | CN1582332A GFP-transfected clon pig, GT knoc-out clon pig and methos for production thereof |
| 02/16/2005 | CN1582331A Endothelial cells derived from primate embryonic stem cells |
| 02/16/2005 | CN1582330A In-vitro micro-organs and uses realated thereto |
| 02/16/2005 | CN1582329A New biopesticide using gene from erwinia pyrifoliaeWT#3, novel pathogen that affects asian pear trees |
| 02/16/2005 | CN1582165A Antibodies to CD40 |
| 02/16/2005 | CN1582156A Methods for treating ocular neovascular diseases |
| 02/16/2005 | CN1580256A Tissue engineered peripheral nerve graft |
| 02/16/2005 | CN1580255A Tissue engineered peripheral nerve graft |
| 02/16/2005 | CN1580254A Tissue engineered peripheral nerve graft |
| 02/16/2005 | CN1580253A Tissue engineered peripheral nerve graft |
| 02/16/2005 | CN1580251A Method for efficiently establishing pure line gene knock-out mouse model |
| 02/16/2005 | CN1580250A Method for establishing mouse full-genome mutoation ES cell bank |
| 02/16/2005 | CN1580249A Method for screening and establishing mouse-development-related gene mutation ES cell bank |
| 02/16/2005 | CN1580248A Method for configurating feeder-layer-free corneal eipithelium for frost self-corneal limbus stem cell |
| 02/16/2005 | CN1580247A Esophagus carcinoma monoclonal antibody, and its radioactive marker and chemical cross-linked substance, and its use |
| 02/16/2005 | CN1580246A Method for inducing embryonic stem cell to differentiate into pancreatic island sample cell |
| 02/16/2005 | CN1580072A SARS coronary virus nail protein high-immune-protosegment, coding sequence and its use |
| 02/16/2005 | CN1189564C Modulators of the function of receptors of the TNF/NGF receptor family |
| 02/16/2005 | CN1189557C Detecting and trapping receptor 3 monoclonal antibody, hybrid tumor for producing said antibody and its use |
| 02/16/2005 | CN1189483C Humanized CD3-resisting monoclonal antibody |
| 02/16/2005 | CN1189209C Application of osteogenic growth peptide in promoting bematogenesis |
| 02/16/2005 | CN1189076C Process for screening anti type-C hepatitis virus medicines |
| 02/15/2005 | US6855875 Soybean variety XB33S03 |
| 02/15/2005 | US6855874 Soybean variety 91B42 |
| 02/15/2005 | US6855864 Methods for simultaneous control of lignin content and composition, and cellulose content in plants |
| 02/15/2005 | US6855812 P-glycoproteins and uses thereof |
| 02/15/2005 | US6855810 Ligands directed to the non-secretory component, non-stalk region of plgR and methods of use thereof |
| 02/15/2005 | US6855809 Chimeric immunoglobulin for detecting hepatitis c viral (HVC) infections and/or contaminated blood products; diagnosis and viral diseases |
| 02/15/2005 | US6855808 Prevent cell differentiation; culture product; genetic engineered protein |
| 02/15/2005 | US6855806 Comprises secreted polypeptide for diagnosis and treatment of tumors, nervous system, reproductive and muscular disorder |
| 02/15/2005 | US6855803 Protein having hemolytic activity and gene encoding the protein |
| 02/15/2005 | US6855802 Mutated peptide compounds, derived from hsp70, useful in cancer immunotherapy |
| 02/15/2005 | US6855691 Methods for producing and using S-nitrosohemoglobins |
| 02/15/2005 | US6855688 ADP-ribosyl transferase fusion proteins, pharmaceutical compositions, and methods of use |
| 02/15/2005 | US6855687 Administering to the site in need of cartilage repair a polypeptide having the sequence Ala-Gly-Tyr-Lys-Pro-Asp-Glu-Gly-Lys-Arg-Gly-Asp-Ala-Cys-Glu-Gl y-Asp-Ser-Pro-Phe-Val |
| 02/15/2005 | US6855683 Hypersensitive response elicitor from Erwinia amylovora, its use, and encoding gene |
| 02/15/2005 | US6855547 Culture product; plant growth regulators; plant for antipyretic therapy |
| 02/15/2005 | US6855542 Liver assist device for propagating/culturing hepatocytes; microfluidics |
| 02/15/2005 | US6855536 Materials and methods for the enhancement of effective root nodulation in legumes |
| 02/15/2005 | US6855535 Comprises serum-free culture; protease-free |
| 02/15/2005 | US6855534 Enhanced system for construction of adenovirus vectors |
| 02/15/2005 | US6855533 Structure-based designed herbicide resistant products |
| 02/15/2005 | US6855532 Gene therapy; drug screening |
| 02/15/2005 | US6855529 DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants |
| 02/15/2005 | US6855519 Methods for enhancing the production of interferon in cell culture |
| 02/15/2005 | US6855489 Systems and methods for removing viral agents from blood |
| 02/15/2005 | US6855365 Recombinant bacterial phytases and uses thereof |
| 02/15/2005 | US6855321 Polyepitope carrier protein |
| 02/15/2005 | US6855317 Immunological herpes simplex virus antigens and methods for use thereof |
| 02/15/2005 | US6855102 Method for separating cells, especially platelets, and bag assembly therefor |
| 02/15/2005 | US6854422 Growing marine fish in fresh water |
| 02/15/2005 | CA1341473C Regeneration of graminaceous plants of the subfamily pooideae from protoplasts |
| 02/10/2005 | WO2005012530A2 Antagonists and agonists of ldcam and methods of use |
| 02/10/2005 | WO2005012527A1 Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof |
| 02/10/2005 | WO2005012519A1 Transposon transferase and use thereof |
| 02/10/2005 | WO2005012513A1 Reversibly immortalised olfactory ensheathing glia and their use to promote neuronal regenaration |
| 02/10/2005 | WO2005012512A1 Scaffold-free self-organized 3d synthetic tissue |
| 02/10/2005 | WO2005012511A1 Agent for maintaining embryonic stem cells in undifferentiated state |
| 02/10/2005 | WO2005012510A1 Method for the isolation and expansion of cardiac stem cells from biopsy |
| 02/10/2005 | WO2005012509A2 Method for immunotherapy of tumors |
| 02/10/2005 | WO2005012508A1 Skin regeneration system |
| 02/10/2005 | WO2005012507A1 Production of plant secondary metabolites using adsorption and elicitation in cell suspension culture |
| 02/10/2005 | WO2005012506A2 Extended primary retinal cell culture and stress models, and methods of use |
| 02/10/2005 | WO2005012504A1 Cell cultivation and breeding method |
| 02/10/2005 | WO2005012496A2 Novel nucleic acids from sesame plants |
| 02/10/2005 | WO2005012492A2 Human skin equivalents expressing exogenous polypeptides |
| 02/10/2005 | WO2005012480A2 Systems and methods for separating and concentrating regenerative cells from tissue |
| 02/10/2005 | WO2005012479A2 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 02/10/2005 | WO2005012351A2 Novel functions for decay accelerating factor (daf) in inflammation |
| 02/10/2005 | WO2005011844A1 Support for immobilising catalytically active units |
| 02/10/2005 | WO2005011765A1 Method of constructing artificial joint |
| 02/10/2005 | WO2005011729A1 Human prostate cell lines in cancer treatment |
| 02/10/2005 | WO2005011599A2 Antibodies specific for toxic amyloid beta protein oligomers |
| 02/10/2005 | WO2005011569A2 Methods of using adipose tissue-derived cells in augmenting autologous fat transfer |
| 02/10/2005 | WO2005011524A1 Three-dimentional tissue structure |
| 02/10/2005 | WO2004112748A3 Rate controlled release of a pharmaceutical agent in a biodegradable device |
| 02/10/2005 | WO2004106924A3 Testing cell cycle regulation effect of a compound using a hollow fibre cell implant |
| 02/10/2005 | WO2004096245A3 Muscle derived cells (mdcs) for promoting and enhancing nerve repair and regeneration |
| 02/10/2005 | WO2004092397A3 Tmprss2 regulatory sequences and uses thereof |
| 02/10/2005 | WO2004078916A3 In vitro micro-organs, and uses related thereto |
| 02/10/2005 | WO2004024068A3 Novel composition and methods for the treatment of immune related diseases |
| 02/10/2005 | WO2004003207A9 Production of peptides and proteins by accumulation in plant endoplasmic reticulum-derived protein bodies |
| 02/10/2005 | WO2003086175A8 Compositions and methods for the therapy and diagnosis of lung cancer |
| 02/10/2005 | WO2003060065A3 Adapter-directed display system |
| 02/10/2005 | WO2003030624A3 Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof |
| 02/10/2005 | WO2003025117A3 Cloning and sequencing of pyruvate decarboxylase (pdc) genes from bacteria and uses therefor |
| 02/10/2005 | WO2002072872A3 System for screening fatty acid transport inhibitors, methods of use and modulators identified thereby |
| 02/10/2005 | WO2002064626A3 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 02/10/2005 | WO2002020718A3 Osteoclast-associated receptor |
| 02/10/2005 | US20050034199 Transgenic seed for propagation of insect resistance, herbicide resistance and disease resistance plants |
| 02/10/2005 | US20050034198 Inbred corn line G0302 |
| 02/10/2005 | US20050034194 Gene controlling flowering time of plants and method for manipulating flowering time of plant using the same |
| 02/10/2005 | US20050034192 Expression vector comprising tissue specific regulatory sequences for use tool in controlling heterologous gene expression in plants; generating insect resistant plants |
| 02/10/2005 | US20050034190 Transgenic soybean seeds exhibiting an oil composition comprising 55 to 80% by weight oleic acid, 10 to 40% by weight linoleic acid, 6% or less by weight linolenic acid, and 2 to 8% by weight saturated fatty acids for use in ehancing applicability in food, biodiesel and biolube markets |
| 02/10/2005 | US20050034185 Melanocortin-3 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight |
| 02/10/2005 | US20050034184 Transgenic papp-a non-human mammals |
| 02/10/2005 | US20050034182 Transgenic mouse with genome DNA sequence encoding a mutated human tau protein linked to promoter; mouse brain exhibits neurofibrillary tangles; Alzheimer*s and neurodegenerative disease |
| 02/10/2005 | US20050034181 Unactivated oocytes as cytoplast recipients for nuclear transfer |
| 02/10/2005 | US20050034177 Genetic modification of male germ cells for generation of transgenic species & genetic therapies |
| 02/10/2005 | US20050034175 Immune cloning and uses thereof |